key: cord-0837901-gnt0arw1
authors: Rouai, Meriem; Slimane, Malek Ben; Sassi, Wiem; Alaoui, Fatima; Chelly, Ines; Mokni, Mourad
title: Pustular rash triggered by Pfizer‐BioNTech COVID‐19 vaccination: A case report
date: 2022-04-01
journal: Dermatol Ther
DOI: 10.1111/dth.15465
sha: 43359e4b8b0930c7f48c79482a2e6d1f1f493c94
doc_id: 837901
cord_uid: gnt0arw1

nan

receptor antagonist gene mutation supports the theory that the two diseases might share a common pathomechanism. 8, 9 Further studies with a large number of samples are needed to determine if these two diseases reflect the continuous spectrum of the same disorder. To F I G U R E 1 A plaque whose active borders are studded with nonfollicular pinhead-sized pustules and desquamation, affecting the trunk

COVID-19 vaccine-induced acute generalized exanthematous pustulosis

A generalized pustular psoriasis flare after CoronaVac COVID-19 vaccination: case report

National survey of psoriasis flares after 2009 monovalent H1N1/seasonal vaccines

Generalized exacerbation of psoriasis vulgaris induced by pneumococcal polysaccharide vaccine

Psoriasis flare after influenza vaccination in Covid-19 era: a report of four cases from a single center

Interferon-alpha and viral triggers promote functional maturation of human monocyte-derived dendritic cells

Th17 cytokines and vaccine-induced immunity

Acute generalized exanthematous pustulosis caused by dihydrocodeine phosphate in a patient with psoriasis vulgaris and a heterozygous IL36RN mutation

Immunohistochemical comparison of IL-36 and the IL-23/Th17 axis of generalized pustular psoriasis and acute generalized exanthematous pustulosis